Where Pain Hides Deep: Ultrasound-Guided Management of a Rare Brachialis Myotendinous Cyst.

Am J Phys Med RehabilMar 26, 2026 (epub)
Case ReportRadiology (Diagnostic)Orthopedic Surgery

Berkay Yalçınkaya, Ahmet Furkan Çolak, Harun Kürşat Karademir et al.

✦ AI-curated · Sources linked

Case in brief

A 20-year-old man developed antecubital fossa pain after heavy lifting, persisting for 1 month. Ultrasound showed a well-defined cystic lesion at the brachialis myotendinous junction, and sonopalpation reproduced his symptoms. Ultrasound-guided aspiration and corticosteroid injection provided immediate relief.

What made this case unusual

The symptomatic cyst was located at the brachialis myotendinous junction, an uncommon site for an elbow cystic lesion.

Diagnostic / clinical pearl

Ultrasound can localize an elbow cystic lesion, while sonopalpation can help establish whether it corresponds to the patient’s pain.

Source

PubMed · PMID 41985179

Published in Am J Phys Med Rehabil. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Radiology (Diagnostic)

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.